B
BFRI
Biofrontera Inc
1.030
-0.010-0.96%Closed19:38 04/10 EDT
OPEN/PREV CLOSE1.040/1.040
TODAY RANGE1.010-1.050
VOL69.56K
MARKET CAP12.00M
52 WEEK RANGE0.5360-1.190
AVG VOL (3M)373.65K
% TURNOVER0.60%
TURNOVER0
P/E (TTM)-0.9944
% RANGE3.85%
EPS(TTM)-1.0358
P/E(FORWARD)-29.4286
P/B1.145
BVPS0.8997
DIVIDEND--
P/S0.2877
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP9.53M
SHARES OUTSTANDING11.65M
NEXT EARNINGS05/13-05/18
FREE FLOAT9.25M
LOT SIZE1
EX-DATE07/05/2023
News
Press Releases
Financial Reports
Profile
TipRanks·03/20 13:17
Roth MKM Reaffirms Their Buy Rating on Biofrontera (BFRI)
TipRanks·03/20 00:09
Biofrontera Earnings Call: Profits Rise, Risks Remain
Seeking Alpha·03/19 19:18
Biofrontera reports rise in Q4 revenue, turns profitable
Seeking Alpha·03/19 19:12
Biofrontera outlines 80%-85% gross margin target for 2026 following strategic asset acquisition
Dow Jones·03/19 13:26
*Biofrontera 4Q Net $5.64M >BFRI
Dow Jones·03/19 13:26
*Biofrontera 4Q Rev $17.1M >BFRI
Reuters·03/19 13:25
BRIEF-Biofrontera Q4 Revenue USD 17.1 Million
Benzinga·03/19 11:11
Earnings Scheduled For March 19, 2026
TipRanks·03/09 13:49
Biofrontera Reports Positive Phase 2b Acne Trial Results
TipRanks·03/09 13:27
Biofrontera reports Phase 2b results of Ameluz PDT in acne vulgaris
Reuters·03/09 13:15
BIOFRONTERA INC - TO PRESENT PHASE 2B DATA TO FDA IN Q3 2026 FOR AMELUZ PDT
Same Industry
Name/Symbol
Change%
Price